- Home
- SI vs RXST Comparison
SI vs RXST Comparison
Compare SI & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SI | RXST |
|---|---|---|
| Founded | 2009 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.1M | 232.2M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SI | RXST |
|---|---|---|
| Price | $20.99 | $5.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 10 |
| Target Price | ★ $20.80 | $9.78 |
| AVG Volume (30 Days) | 148.5K | ★ 1.4M |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $134,479,000.00 |
| Revenue This Year | $39.59 | N/A |
| Revenue Next Year | $31.37 | $10.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.92 | $4.48 |
| 52 Week High | $23.00 | $13.22 |
Technical Indicators
Market Signals| Indicator | SI | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 54.79 | 56.56 |
| Support Level | $12.79 | $5.30 |
| Resistance Level | $22.92 | $5.90 |
| Average True Range (ATR) | 1.58 | 0.45 |
| MACD | -0.17 | 0.07 |
| Stochastic Oscillator | 37.70 | 73.03 |
Price Performance
Historical ComparisonAbout SI Shoulder Innovations Inc.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.